MEET THE TEAM

Kevin Kane
Founder & President

Kevin started his statistical career in 1990 with Amgen. After three years, he moved to Wellcome and stayed in the GSK family of companies for a number of years. Having held a variety of positions, including project statistician and technical support gives Kevin a broad oversight of the clinical trial process. Kevin set up PHASTAR in 2007 and is a Chartered Statistician and a former Board Member for PSI (Statisticians in the Pharmaceutical Industry). He is still actively involved in providing statistical support.

Andrew MacGarvey
Chief Executive Officer

Andrew began his career in statistical programming nearly 25 years ago and subsequently held various technical roles in contract research organizations. He has served on several boards and has worked in both the UK and the USA in leadership roles with a focus on growing businesses. Andrew is committed to delivering the best in customer service, creating an excellent working environment, and ensuring PHASTAR gives back to the wider community through initiatives such as our Pro Bono scheme. He holds a Law degree from the Open University and an MBA from Newcastle University.

Chuck Gelb
Chief Commercial Officer

Holding an MBA in Pharmaceutical Management and an MA in Biotechnology, Chuck brings to PHASTAR over 20 years’ experience across pharmaceutical companies and CROs. His unique blend of experience provides critical insight into the needs of sponsors, as well as the knowledge to build and manage a large, global sales and marketing team and provide liaison between board, operations, and sales. As a member of PHASTAR’s executive management team, Chuck directs the commercial strategy in line with the company’s vision alongside driving the development of new talent within the organization and taking accountability for business targets and budgets.

Sheelagh Aird
Digital Health and Data Science

With more than 30 years of experience in clinical data management, Sheelagh has directed and delivered projects in all phases of clinical trials across numerous therapeutic areas and data collection platforms. Sheelagh holds a BSc in pharmacology and doctorate in pharmacokinetics from the University of Bath. She has led PHASTAR’s Data Operations group since 2016.

Pamela Rennie
Senior Director, Alliances and Biostatistics

Pam joined the PHASTAR team after working in statistical and alliance management roles for more than 20 years in a large pharmaceutical company. Pam has extensive knowledge and experience of working within an alliance framework, from the initial vendor selection process through to establishing new partnerships, whilst effectively managing existing relationships. She has developed strong connections with a variety of analysis and reporting customers, ranging from models working with low cost offshore providers to large global organizations. Alongside this, Pam works with multiple global internal teams within the pharmaceutical industry to meet their reporting and regulatory requirements.

Nadeem Elahi
Head, Customer and Business Strategy

Prior to joining PHASTAR, Nadeem had over 26 years' experience at GSK in a variety of analytical roles supporting drug development through to commercialization. During his early career, he provided statistical consultancy to non-clinical and clinical projects across multiple therapeutic areas and phases of development. Nadeem was responsible for driving the GSK statistics and programming resourcing strategy globally, building strong partnerships with external functional service providers, while managing internal stakeholders. Nadeem joined PHASTAR in 2015 taking responsibility for account strategy and management for some of our largest clients.

Professor Jennifer Rogers
VP, Statistical Research & Consultancy

Jen joined PHASTAR in August 2019, following a move from the University of Oxford where she was Director of Statistical Consultancy Services and an Associate Professor in the Department of Statistics. She had previously worked as a Post-Doctoral Research Fellow funded by the National Institute of Health Research. Formerly Vice President for External Affairs at the Royal Statistical Society and now a member of its COVID-19 task force and a trustee of the Florence Nightingale Museum, Jen directs the statistical research strategy, helping the company stay at the cutting edge of new methodological advances, as well as being technical lead for the Expert Strategic Consultancy group. Jen is a popular statistics presenter and can often be heard on the radio or seen on TV screens.

Alastair Sword
Senior Director, Operational Excellence

Alastair is a statistician with over 25 years of experience as both a manager and hands-on statistician across multiple therapeutic areas within the pharmaceutical industry. With his expertise in managing groups that deliver projects to tight timelines, Alastair has developed a passion for process improvement and the integration of systems. Within PHASTAR he is responsible for the Operational Excellence team and the Programme of internal projects, that deliver efficiencies and ensure quality, and provides oversight of the Quality Assurance function. As a member of the senior management team, Alastair matches the evolving business needs with updates to current processes and tools and helps manage the transition. He holds a BSc in Mathematics and MSc in Statistics

Dr Paul Stark
VP and US Country Manager

Alastair is a statistician with over 25 years of experience as both a manager and hands-on statistician across multiple therapeutic areas within the pharmaceutical industry. With his expertise in managing groups that deliver projects to tight timelines, Alastair has developed a passion for process improvement and the integration of systems. Within PHASTAR he is responsible for the Operational Excellence team and the Programme of internal projects, that deliver efficiencies and ensure quality, and provides oversight of the Quality Assurance function. As a member of the senior management team, Alastair matches the evolving business needs with updates to current processes and tools and helps manage the transition. He holds a BSc in Mathematics and MSc in Statistics.

Dr Jennifer Bradford
Director, Data Science

Jenny leads PHASTAR’s data science group, a team of experienced data scientists that are applying advanced analytical approaches, including artificial intelligence and machine learning to maximize the value of clinical trial data. Jenny’s background in data science spans over 18 years and prior to joining PHASTAR in 2019, Jenny worked for AstraZeneca and Cancer Research UK.

Michelle Thomson
Senior Director, Project Management Office

Michelle began her career in the pharmaceutical industry in 1998, working in both pharmaceutical companies and CROs. Initially working as a statistician, she has experience in phase II-IV clinical trials across a wide range of therapeutic areas. After a transition into resource management she now heads up the Project Management Office, overseeing the program of work across PHASTAR to ensure projects are delivered on time, on budget and of the highest quality.

Ryan Hara
Director of Biometrics

With a background in programming, Ryan has extensive experience working in the pharmaceutical and CRO industry and leading a clinical analytics department in both Japan and China. Ryan is responsible for delivering PHASTAR’s business strategy in Japan – business development, plans and processes for delivery of clinical trial projects, alongside staff recruitment and development. Ryan also provides oversight of clinical trial projects to ensure they are delivered to agreed timelines with optimal quality.

Barbara Ramambason
Director, Strategic Programming Support

Barbara began her career in programming over 20 years ago and held various programming and leadership positions in the pharmaceutical industry prior to joining PHASTAR in 2017. As Head of Strategic Programming Support, Barbara provides technical and strategic programming support within the company, including technical programming input to RFIs and RFPs for prospective and existing clients, providing technical programming advice to technical support for internal reporting teams and advising on programming best practices for the reporting of clinical trial and regulatory submissions.

James Zee
Director, Programming

James started his programming career at a global CRO before moving to Pharma, spending the majority of his career based in Basel, Switzerland. James' 23 years of experience includes early and late-phase clinical trials, HTA and e-Submissions. James leads PHASTAR’s global programming group from our Sheffield office, focusing on providing the highest quality of programming expertise to PHASTAR’s clients.
Learn more about our services
We are experts in study design, statistical analysis, data science, data capture and reporting for clinical trials